Breaking News Instant updates and real-time market news.

SNDX

Syndax

$11.15

-0.41 (-3.55%)

16:07
08/10/17
08/10
16:07
08/10/17
16:07

Syndax reports Q2 EPS (70c), consensus (83c)

Reports Q2 revenue $305,000, consensus $300,000.

SNDX Syndax
$11.15

-0.41 (-3.55%)

03/16/17
03/16/17
INITIATION
Target $27

Outperform
Syndax initiated with an Outperform at FBR Capital
FBR Capital analyst Edward White started Syndax Pharmaceuticals with an Outperform rating and $27 price target.
03/24/17
COWN
03/24/17
INITIATION
COWN
Outperform
Syndax initiated with an Outperform at Cowen
Cowen analyst Chris Shibutani initiated Syndax with an Outperform commenting it is poised to succeed in developing entinostat for advanced HR+ breast cancer. Additional upside could be driven by IO combination studies, which capitalize on entinostat's unique mechanism of action, complementary to checkpoint inhibitors.
05/18/17
SBSH
05/18/17
NO CHANGE
Target $24
SBSH
Buy
Syndax price target raised to $24 from $20 at Citi
Citi analyst Joel Beatty raised his price target for Syndax Pharmaceuticals to $24 saying he's encouraged by the early response data reported yesterday afternoon for Entinostat plus Keytruda in melanoma. The data are compelling enough to increase the drug's probability of approval in melanoma to 30% from 20%, Beatty tells investors in a research note. He keeps a Buy rating on Syndax.
05/18/17
JMPS
05/18/17
NO CHANGE
JMPS
Syndax data 'impressive,' says JMP Securities
JMP Securities analyst Michael King says that the objective response rate for the company's entinostat in melanoma patients in a Phase 1b/Phase II trial was "impressive." The analyst remains upbeat on the treatment and keeps an Outperform rating on the stock.

TODAY'S FREE FLY STORIES

CRAY

Cray

$21.35

0.6 (2.89%)

07:07
11/21/17
11/21
07:07
11/21/17
07:07
Upgrade
Cray rating change  »

Cray upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ARQL

ArQule

$1.40

-0.02 (-1.41%)

07:06
11/21/17
11/21
07:06
11/21/17
07:06
Hot Stocks
ArQule announces dosing in registrational trial of Derazantinib »

ArQule announced dosing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$57.88

-0.26 (-0.45%)

07:06
11/21/17
11/21
07:06
11/21/17
07:06
Hot Stocks
Target announces 15% off sitewide sale on Target.com on Cyber Monday »

Target unveiled its plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIG

Signet Jewelers

$75.84

-0.74 (-0.97%)

07:06
11/21/17
11/21
07:06
11/21/17
07:06
Hot Stocks
Breaking Hot Stocks news story on Signet Jewelers »

Signet Jewelers down 17%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 07

    Dec

  • 08

    Dec

LE

Land's End

$12.70

0.3 (2.42%)

07:06
11/21/17
11/21
07:06
11/21/17
07:06
Hot Stocks
Land's End appoints Gill Hong Chief Merchandising Officer »

Lands' End (LE)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NJR

New Jersey Resources

$44.30

-0.45 (-1.01%)

07:05
11/21/17
11/21
07:05
11/21/17
07:05
Earnings
New Jersey Resources sees FY18 net financial EPS $1.75-$1.85, consensus $1.88 »

NJR announced fiscal 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

PDCO

Patterson Companies

$34.82

-1.22 (-3.39%)

07:05
11/21/17
11/21
07:05
11/21/17
07:05
Earnings
Patterson revises FY18 adjusted EPS view to $2.00-$2.10 from $2.25-$2.40 »

Consensus $2.29.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 28

    Nov

GNMSF

Genmab

$186.00

-7.4706 (-3.86%)

, JNJ

Johnson & Johnson

$137.93

-0.07 (-0.05%)

07:04
11/21/17
11/21
07:04
11/21/17
07:04
Hot Stocks
Genmab announces European regulatory submission for daratumumab »

Genmab (GNMSF) announced…

GNMSF

Genmab

$186.00

-7.4706 (-3.86%)

JNJ

Johnson & Johnson

$137.93

-0.07 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

VRTV

Veritiv

$24.60

0.1 (0.41%)

07:04
11/21/17
11/21
07:04
11/21/17
07:04
Upgrade
Veritiv rating change  »

Veritiv upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NJR

New Jersey Resources

$44.30

-0.45 (-1.01%)

07:04
11/21/17
11/21
07:04
11/21/17
07:04
Earnings
New Jersey Resources reports Q4 EPS (14c), consensus (13c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

KORS

Michael Kors

$56.15

-0.14 (-0.25%)

07:03
11/21/17
11/21
07:03
11/21/17
07:03
Recommendations
Michael Kors analyst commentary  »

Jefferies upside case has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

KMDA

Kamada

$4.65

-0.05 (-1.06%)

07:03
11/21/17
11/21
07:03
11/21/17
07:03
Hot Stocks
Kamada announces new supply agreement with international organization for KamRAB »

Kamada announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDCO

Patterson Companies

$34.82

-1.22 (-3.39%)

07:02
11/21/17
11/21
07:02
11/21/17
07:02
Earnings
Patterson Companies reports Q2 adjusted EPS 51c, consensus 54c »

Reports Q2 revenue $1.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 28

    Nov

BLRX

BioLineRx

$1.05

0.04 (3.96%)

07:02
11/21/17
11/21
07:02
11/21/17
07:02
Earnings
BioLineRx reports Q3 EPS (7c), consensus (9c) »

The company held $55M in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

SIG

Signet Jewelers

$75.84

-0.74 (-0.97%)

, ADS

Alliance Data

$224.67

0.32 (0.14%)

07:02
11/21/17
11/21
07:02
11/21/17
07:02
Hot Stocks
Signet in advanced talks with interested partners on more credit outsourcing »

On October 23, Signet…

SIG

Signet Jewelers

$75.84

-0.74 (-0.97%)

ADS

Alliance Data

$224.67

0.32 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 30

    Nov

  • 07

    Dec

  • 08

    Dec

  • 14

    Dec

ENSV

Enservco

$0.65

0.0196 (3.11%)

07:02
11/21/17
11/21
07:02
11/21/17
07:02
Hot Stocks
Enservco enters into agreement with bank »

Enservco announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$22.53

0.38 (1.72%)

07:02
11/21/17
11/21
07:02
11/21/17
07:02
Earnings
DSW sees FY17 adjusted EPS $1.40-$1.45, consensus $1.50 »

FY17 outlook reflects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

DSW

DSW

$22.53

0.38 (1.72%)

07:00
11/21/17
11/21
07:00
11/21/17
07:00
Earnings
DSW reports Q3 adjusted EPS 45, consensus 53c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

SIG

Signet Jewelers

$75.84

-0.74 (-0.97%)

07:00
11/21/17
11/21
07:00
11/21/17
07:00
Earnings
Signet Jewelers lowers FY18 EPS view to $6.10-$6.50 from $7.16-$7.56 »

Consensus $7.02. Lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 07

    Dec

  • 08

    Dec

RXDX

Ignyta

$15.75

0.85 (5.70%)

07:00
11/21/17
11/21
07:00
11/21/17
07:00
Initiation
Ignyta initiated  »

Ignyta initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

LSI

Life Storage

$87.95

-0.73 (-0.82%)

07:00
11/21/17
11/21
07:00
11/21/17
07:00
Upgrade
Life Storage rating change  »

Life Storage upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SC

Santander Consumer

$17.07

0.75 (4.60%)

06:59
11/21/17
11/21
06:59
11/21/17
06:59
Recommendations
Santander Consumer analyst commentary  »

Santander Consumer added…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

06:59
11/21/17
11/21
06:59
11/21/17
06:59
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRIX

IRIDEX

$7.63

-0.09 (-1.17%)

06:59
11/21/17
11/21
06:59
11/21/17
06:59
Conference/Events
IRIDEX management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

SIG

Signet Jewelers

$75.84

-0.74 (-0.97%)

06:58
11/21/17
11/21
06:58
11/21/17
06:58
Earnings
Signet Jewelers now sees FY18 EPS $6.10-$6.50, consensus $7.02 »

Signet CEO Virginia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 07

    Dec

  • 08

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.